By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroVive Pharmaceutical AB 

Biomedical Center

Sölvegatan 19    SE-221 84 Lund  Sweden
Phone: 46-0-46-288-0110 Fax: 46-0-46-888-8348


NeuroVive Pharmaceutical is a pioneer in mitochondrial research and development. The focus is on developing drug candidates that maintain mitochondrial integrity and improves their function for indications with unmet medical needs. Research and development is conducted both in-house and in collaboration with renowned international partners.




Founder: Eskil Elmér

CEO: Erik Kinnman

CSO and Founder: Eskil Elmér

Key Statistics

Ownership: Public

Web Site: NeuroVive
Symbol: NVP


Company News
NeuroVive (NVP) Presents Preclinical Findings Of NV556 In NASH Showing Confirmatory Anti-Fibrotic Effects 4/20/2017 6:39:24 AM
Number Of Shares And Votes In NeuroVive (NVP) 3/31/2017 8:57:22 AM
NeuroVive (NVP) Publishes 2016 Annual Report 3/23/2017 9:34:09 AM
Notice Of Annual General Meeting Of Shareholders In NeuroVive (NVP) 3/23/2017 8:30:38 AM
NeuroVive (NVP) Appoints Recognized Scientific Advisors And Enters Research Agreements In NASH And Hepatocellular Carcinoma 2/22/2017 6:46:44 AM
NeuroVive (NVP) Year End Report January - December 2016 2/21/2017 9:36:30 AM
NeuroVive (NVP)'s New Generation Of Sanglifehrin-Based Compounds Demonstrate Potent Inhibitory Effects On Human Hepatocellular Cancer Cells 2/2/2017 8:27:38 AM
NeuroVive (NVP) Release: Company Redirects Research Resources From Asian Subsidiary To Parent 1/25/2017 11:56:03 AM
NeuroVive (NVP) Release: Company Signs Mitochondrial Medicine Research Agreement With US Key Opinion Leader 1/23/2017 8:39:45 AM
NeuroVive (NVP) Release: Pharma Presents Positive Preclinical Data In Hepatocellular Cancer At HCC Summit 1/19/2017 8:05:18 AM